News Focus
News Focus
Replies to #26944 on Biotech Values
icon url

iOwnSomeBio

04/08/06 9:28 AM

#26945 RE: DewDiligence #26944

Lovenox has always had these competitors (fondiparinux, dalteparin, etc.). It continues to hold the majority of the market - $3 bil. These competitors are not new. MNTA is hoping to get a split of the $3 bil that lovenox now holds.